Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07179614 · ClinicalTrials.gov registry record · NA
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
A NA study, sponsored by Michele Staton.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT07179614: Recruiting NA study, sponsored by Michele Staton.
NCT07179614 is a NA study that is actively recruiting participants, run by Michele Staton. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07179614, a NA study, is actively recruiting participants, sponsored by Michele Staton.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.
Primary Outcome
Overdose risk score based on days of opioid, stimulant, and polysubstance use
Interventions
- BEHAVIORAL Overdose Prevention Intervention Package (OPIP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-06-23 |
| Est. Completion | 2030-10-30 |
| Phase | NA |
What NCT07179614 shows while recruiting
NCT07179614 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Overdose Prevention Intervention Package (OPIP) is the first listed.
NCT07179614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07179614 about?
NCT07179614 is a clinical study titled "Kentucky Women's Justice Community Overdose Innovation Network - Phase II". This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effe...
What is the current status of trial NCT07179614?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-06-23. Estimated completion is 2030-10-30.
What interventions are being tested in trial NCT07179614?
The interventions under investigation include: Overdose Prevention Intervention Package (OPIP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07179614?
This trial is sponsored by Michele Staton, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07179614's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI